Company Accounts and Tax Online 15542509 Board of Directors 6.3.24 31.3.25 31.3.25 No description of principal activity false iso4217:GBP xbrli:pure 15542509 2025-03-31 15542509 2024-03-06 2025-03-31 15542509 countries:EnglandWales 2024-03-06 2025-03-31 15542509 curr:PoundSterling 2024-03-06 2025-03-31 15542509 uk-bus:PrivateLimitedCompanyLtd 2024-03-06 2025-03-31 15542509 uk-bus:FRS102 2024-03-06 2025-03-31 15542509 uk-bus:AuditExempt-NoAccountantsReport 2024-03-06 2025-03-31 15542509 uk-bus:AbridgedAccounts 2024-03-06 2025-03-31 15542509 uk-bus:RegisteredOffice 2024-03-06 2025-03-31 15542509 uk-bus:Director1 2024-03-06 2025-03-31 15542509 uk-bus:Director1 2024-03-06 15542509 uk-bus:Director1 2025-03-31 15542509 core:AfterOneYear 2025-03-31 15542509 core:WithinOneYear 2025-03-31 15542509 core:WithinOneYear 2024-03-06 2025-03-31 15542509 core:AfterOneYear 2025-03-31 15542509 core:AfterOneYear 2024-03-06 2025-03-31 15542509 core:ShareCapital 2025-03-31 15542509 core:RevaluationReserve 2025-03-31 15542509 core:RetainedEarningsAccumulatedLosses 2025-03-31 15542509 1 2024-03-06 2025-03-31

# MYRAPHIDAN LIMITED

## Company Registration Number:
15542509 (England and Wales)

## Unaudited abridged accounts for the year ended 31 March 2025

## Period of accounts

## Start date: 06 March 2024

## End date: 31 March 2025

# MYRAPHIDAN LIMITED

## Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3 |
Report of the Directors - 4 |
Profit and Loss Account - 5 |
Balance sheet - 6 |
Additional notes - 8 |

# MYRAPHIDAN LIMITED

## Company Information

for the Period Ended 31 March 2025

Director: |  | Raphael Daniel
Registered office: |  | 38 Gunning Place Callender Road Erith England DA8 3FD
Company Registration Number: |  | 15542509 (England and Wales)

# MYRAPHIDAN LIMITED

## Directors' Report Period Ended 31 March 2025

The directors present their report with the financial statements of the company for the period ended 31 March 2025

Directors

The director(s) shown below were appointed to the company during the period
Raphael Daniel
06 March 2024

This report was approved by the board of directors on 21 October 2025
And Signed On Behalf Of The Board By:

Name: Raphael Daniel
Status: Director

# MYRAPHIDAN LIMITED

## Profit and Loss Account

for the Period Ended 31 March 2025

| Notes | 13 months to 31 Mar 2025 £
--- | --- | ---
Gross Profit or (Loss) |  | 20
Administrative Expenses |  | ( 650 )
Operating Profit or (Loss) |  | ( 630 )
Profit or (Loss) Before Tax |  | ( 630 )
Profit or (Loss) for Period |  | ( 630 )

The notes form part of these financial statements

# MYRAPHIDAN LIMITED

## Balance sheet

As at 31 March 2025

| Notes | 13 months to 31 Mar 2025 £
--- | --- | ---
Fixed assets
Total fixed assets: |  | -
Current assets
Creditors: amounts falling due after more than one year: |  | ( 650 )
Total net assets (liabilities): |  | ( 650 )

The notes form part of these financial statements

# MYRAPHIDAN LIMITED

## Balance sheet continued

As at 31 March 2025

| Notes | 13 months to 31 Mar 2025 £
--- | --- | ---
Capital and reserves
Called up share capital: |  | 1
Profit and loss account: |  | ( 651 )
Shareholders funds: |  | ( 650 )

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 21 October 2025
And Signed On Behalf Of The Board By:

Name: Raphael Daniel
Status: Director

The notes form part of these financial statements

# MYRAPHIDAN LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

# MYRAPHIDAN LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2025

- ## 2. Employees

  | 13 months to 31 Mar 2025
  --- | ---
  Average number of employees during the period | 0 |

# MYRAPHIDAN LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2025

- ## 3. Off balance sheet disclosure

  No